MarginsXMarginsX
Home › Markets › Health Care › XXII

22nd Century Group Inc. (XXII)

XXII trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.4932
-35.96% on the day
Market cap
$272K
Nano cap
Revenue · 2025
$17.6M
-27.9% on 2024
Net income · 2025
-$5.1M
-28.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1347858/000110465926034814/0001104659-26-034814-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerXXII on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001347858
SEC industry codeCigarettes
Incorporated inFL

Financials · 2025

LineValue
Revenue$17.6M
Net income-$5.1M
Operating income-$11.6M
Net margin-28.7%
Operating margin-65.8%
Revenue growth-27.9%
Cash$7.1M
Total assets$27.0M
P/E (computed)Net income was not positive
P/S (computed)0.0×

Warning signs

Cash runway
8.7 months
$6.1M cash at June 30, 2026
Share count, 1 year
+5735.8%
2025-08-11 to 2026-08-14 · +50483984.8% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Given the Company's projected operating requirements and its existing cash and cash equivalents, there is substantial doubt about the Company's ability to continue as a going concern through one year following the date that the Condensed Consolidated Financial Statements are issued."
10-Q 2026-08-14
Cash and burn$6.1M cash; operating cash flow -$2.1M a quarter.Report 2026-06-30
Shares outstandingNo cover-page share count in XBRLCover page 2026-08-14
Reverse splits, 3 years6; latest 1-for-58 on 2026-11-05Source 2026-11-05
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 6 424B5 takedowns, 3 at the marketLatest 2026-04-10
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWithumSmith+Brown, PC, Buffalo, New York, United States; changed auditors 1 time in 24 months8-K 4.01 2025-08-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$2.9M-$3.3M-$4.0M$6.1M$1.1M$14.5M10-Q 2026-08-14
Q1 2026
2026-03-31
$4.1M-$3.3M-$3.1M$9.5M$588K$15.7M10-Q 2026-05-07
Q4 2025
2025-12-31
$3.5M-$2.8M$2.7M$7.1M$708K$17.6M10-K 2026-03-26
Q3 2025
2025-09-30
$4.0M$5.5M-$4.0M$4.8MNo debt tags$18.1M10-Q 2025-11-04
Q2 2025
2025-06-30
$4.1M-$3.4M-$3.5M$3.1M$3.2M$20.0M10-Q 2026-08-14
Q1 2025
2025-03-31
$6.0M-$4.3M-$3.0M$1.1M$3.9M$23.9M10-Q 2026-05-07
Q4 2024
2024-12-31
$4.0M-$4.6M-$4.4M$4.4M$6.7M$24.4M10-K 2026-03-26
Q3 2024
2024-09-30
$5.9M-$3.8M-$3.0M$5.3M$7.0M$27.7M10-Q 2024-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-10-28
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-16
Latest proxyDEF 14A2026-06-23

Source: SEC EDGAR submissions feed, 922 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-50.3%
1 month-98.0%
3 months-99.7%
Year to date-100.0%
1 year-100.0%
From 52-week high-100.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
IMCCIM Cannabis Corp. Common Shares$0.4950-12.76%$913K
AKANAkanda Corp. Common Shares$2.21+62.50%$5.3M
NAIINatural Alternatives International Inc.$0.9700+0.35%$6.1M
MTEXMannatech Incorporated$3.76-40.32%$7.3M
BONBon Natural Life Limited$1.09-0.91%$8.9M
BTMDBiote Corp.$0.9603-9.83%$34.5M
FTLFFitLife Brands Inc.$6.83-19.46%$64.1M
ISPRIspire Technology Inc.$1.52-10.06%$87.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier